Skip to main content
Fig. 1 | Diabetology & Metabolic Syndrome

Fig. 1

From: Maternal hyperglycemia inhibits pulmonary vasculogenesis during mouse fetal lung development by promoting GβL Ubiquitination-dependent mammalian target of Rapamycin assembly

Fig. 1

The GDM fetal lungs exhibiting deficient alveolar and vascular development. A The RAC determined via H&E staining of the control and GDM fetal lung tissues. B The IHC staining of the control and GDM fetal lung tissues for vWF expression. C The IF staining of the control and GDM fetal lung tissues for CD31 expression. D The MVD evaluation in terms of the GDM and control groups (n = 6 in each group, *p < 0.05, **p < 0.001)

Back to article page